Chinese
|
English
Search:
Home
About Us
President’s Oration
Target
Strategy
Organization Structure
Support of Management
Report
News
Reports
Great Events
Orgnizations
Medical Centre
Group
Licensed Brand Processing
Hongwan Mednet
Innovation
Team
Domain
Innovation
Cooperation
International Communication
Medical Information
Marketing
Sales licensing
Products
New Drug Certificate
Project
Patent Information
APIs
Careers
Declaration
Sense of Worth
Obligation
HR
Medical Centre
News
Clinical New Informations
Drug Regulations
Market Analyze
HOME
>
Orgnizations
>
Medical Centre
>
Clinical New Informations
·
Clavis Company will expand the Phase Ⅲ study of leukemia drug
·
BioAlliance Pharma announced the phase Ⅱtrial results of liver cancer drug Livatag
·
Study on Phase Ⅱ for oral rheumatoid arthritis drug “VX-509” achieved the main objective
Contact Us
010-80720737
manage@huaxipharm.com
Legal Notices
|
Link
|
Contact Us
京ICP备09069091号©2010 Huaxi All rights reserved